ICLR Stock Summary and Trading Ideas (Icon PLC - | NASDAQ:ICLR)

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Icon PLC - trades on the NASDAQ stock market under the symbol ICLR.

As of January 29, 2026, ICLR stock price declined to $182.21 with 71,939 million shares trading.

ICLR has a beta of 0.99, meaning it tends to be less sensitive to market movements. ICLR has a correlation of 0.12 to the broad based SPY ETF.

ICLR has a market cap of $13.91 billion. This is considered a Large Cap stock.

Last quarter Icon PLC - reported $2 billion in Revenue and $3.31 earnings per share. This beat revenue expectation by $62 million and exceeded earnings estimates by $.08.

In the last 3 years, ICLR traded as high as $347.72 and as low as $125.10.

The top ETF exchange traded funds that ICLR belongs to (by Net Assets): JAVA, PIEQ, SPDW, BBHM, DFAT.

ICLR has underperformed the market in the last year with a price return of -9.9% while the SPY ETF gained +14.6%. However, in the short term, ICLR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +2.5% vs +0.1% return in SPY. But in the last 2 weeks, ICLR shares have been beat by the market, returning -1.4% compared to an SPY return of -0.7%.

ICLR support price is $180.93 and resistance is $191.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ICLR shares will trade within this expected range on the day.